ABEMACICLIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 265 adverse event reports in the FDA FAERS database where ABEMACICLIB was used for Neoplasm malignant.
Most Reported Side Effects for ABEMACICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 4,988 | 30.4% | 89 | 812 |
| Fatigue | 1,878 | 11.5% | 23 | 217 |
| Nausea | 1,682 | 10.3% | 27 | 301 |
| Vomiting | 943 | 5.8% | 29 | 331 |
| Malignant neoplasm progression | 890 | 5.4% | 152 | 216 |
| Decreased appetite | 744 | 4.5% | 26 | 179 |
| Death | 696 | 4.3% | 680 | 44 |
| Asthenia | 678 | 4.1% | 18 | 168 |
| Drug ineffective | 668 | 4.1% | 23 | 47 |
| White blood cell count decreased | 566 | 3.5% | 14 | 130 |
| Anaemia | 555 | 3.4% | 48 | 203 |
| Constipation | 513 | 3.1% | 3 | 83 |
| Abdominal pain upper | 509 | 3.1% | 1 | 74 |
| Neutropenia | 509 | 3.1% | 25 | 106 |
| Dehydration | 469 | 2.9% | 15 | 243 |
Other Indications for ABEMACICLIB
Breast cancer (4,719)
Breast cancer female (3,576)
Product used for unknown indication (3,356)
Breast cancer metastatic (1,752)
Breast cancer recurrent (298)
Hormone receptor positive her2 negative breast cancer (220)
Invasive ductal breast carcinoma (145)
Breast cancer stage iv (117)
Bone cancer (90)
Metastases to bone (78)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)